Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Harris

Showing results (181-190 of 682) with videos related to

Pageof 69
Sort By:
Lancet (London, England)|March 24, 1990
Increased expression of mutant forms of p53 oncogene in primary lung cancerR Iggo, K Gatter, J Bartek, et al.
Methods of Information in Medicine|October 1, 1994
Safety and decision support in oncologyP Hammond, A L Harris, S K Das, et al.
British Journal of Cancer|October 1, 1986
Role of aminoglutethimide in male breast cancerA L Harris, M Dowsett, R Stuart-Harris, et al.
Cancer Treatment Reports|April 1, 1986
Hemorrhagic cystitis after i.v. bleomycin, vinblastine, cisplatin, and etoposide for testicular cancerB M Cantwell, A L Harris, D Patrick, et al.
BMJ (Clinical Research Ed.)|July 16, 1988
Thromboses and thromboemboli in patients with lymphoma during cytotoxic chemotherapyB M Cantwell, J Carmichael, S E Ghani, et al.
Mutation Research|March 1, 1988
Bleomycin and X-ray-hypersensitive Chinese hamster ovary cell mutants: genetic analysis and cross-resistance to neocarzinostatinC N Robson, A Hall, A L Harris, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1988
The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16-213, doxorubicin and vincristine (VPAV) for small cell lung cancerB M Cantwell, J M Bozzino, P Corris, et al.
Cancer|September 15, 1989
Single high-dose (45 mg) infusions of aminohydroxypropylidene diphosphonate for severe malignant hypercalcemiaK A Mannix, J Carmichael, A L Harris, et al.
Cancer Research|December 1, 1986
Isolation and characterization of a Chinese hamster ovary cell line resistant to bifunctional nitrogen mustardsC N Robson, J Alexander, A L Harris, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Chemotherapy induced emesis may exacerbate the nephrotoxicity of combined ifosfamide/mesna and cisplatin chemotherapyB M Cantwell, J Carmichael, K A Mannix, et al.
Pageof 69

Showing results (181-190 of 682) with videos related to

Sort By:
Pageof 69
Lancet (London, England)|March 24, 1990
Increased expression of mutant forms of p53 oncogene in primary lung cancerR Iggo, K Gatter, J Bartek, et al.
Methods of Information in Medicine|October 1, 1994
Safety and decision support in oncologyP Hammond, A L Harris, S K Das, et al.
British Journal of Cancer|October 1, 1986
Role of aminoglutethimide in male breast cancerA L Harris, M Dowsett, R Stuart-Harris, et al.
Cancer Treatment Reports|April 1, 1986
Hemorrhagic cystitis after i.v. bleomycin, vinblastine, cisplatin, and etoposide for testicular cancerB M Cantwell, A L Harris, D Patrick, et al.
BMJ (Clinical Research Ed.)|July 16, 1988
Thromboses and thromboemboli in patients with lymphoma during cytotoxic chemotherapyB M Cantwell, J Carmichael, S E Ghani, et al.
Mutation Research|March 1, 1988
Bleomycin and X-ray-hypersensitive Chinese hamster ovary cell mutants: genetic analysis and cross-resistance to neocarzinostatinC N Robson, A Hall, A L Harris, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1988
The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16-213, doxorubicin and vincristine (VPAV) for small cell lung cancerB M Cantwell, J M Bozzino, P Corris, et al.
Cancer|September 15, 1989
Single high-dose (45 mg) infusions of aminohydroxypropylidene diphosphonate for severe malignant hypercalcemiaK A Mannix, J Carmichael, A L Harris, et al.
Cancer Research|December 1, 1986
Isolation and characterization of a Chinese hamster ovary cell line resistant to bifunctional nitrogen mustardsC N Robson, J Alexander, A L Harris, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Chemotherapy induced emesis may exacerbate the nephrotoxicity of combined ifosfamide/mesna and cisplatin chemotherapyB M Cantwell, J Carmichael, K A Mannix, et al.
Pageof 69